Previous studies in prostate cancer have shown that once tumor cells colonize the bone marrow microenvironment, they acquire osteomimicry features—such as the expression of alkaline phosphatase, osteocalcin, osteopontin, and bone morphogenetic proteins (BMPs)—to support their survival and progression within bone tissue [46,47]. The gene discussed is CLN5; the disease is neoplasm.